Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 674

Results For "STI"

6848 News Found

Lupin receives US $50 mn on achieving cancer milestone
News | May 28, 2021

Lupin receives US $50 mn on achieving cancer milestone

MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination


Remdesivir demand was exaggerated: Dr. Sharvil Patel
News | May 28, 2021

Remdesivir demand was exaggerated: Dr. Sharvil Patel

Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines


Zydus seeks DCGI approval for monoclonal antibodies cocktail
Policy | May 27, 2021

Zydus seeks DCGI approval for monoclonal antibodies cocktail

Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants


Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
News | May 27, 2021

Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21

Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21


Sun Pharma Q4 FY21 net profit up 124%
News | May 27, 2021

Sun Pharma Q4 FY21 net profit up 124%

The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year


Pfizer registers Q4FY21net profit at Rs 100 Cr
News | May 26, 2021

Pfizer registers Q4FY21net profit at Rs 100 Cr

Revenue from operations for the year ended March 31, 2021 is ?2,239 crore


Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
News | May 25, 2021

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma

The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr


Cipla to market Roche's Antibody Cocktail in India
Policy | May 25, 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19


Glenmark receives ANDA approval for Icatibant Injection
News | May 25, 2021

Glenmark receives ANDA approval for Icatibant Injection

This marks Glenmark's first synthetic decapeptide injectable approval


Everest Organics launches 'Posaconazole' API
News | May 25, 2021

Everest Organics launches 'Posaconazole' API

Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients